Answers are grounded in this paper and cite their sources.
A formulation of quercetin-based solid lipid nanoparticles (QSLNs) was developed to increase the bioavailability of quercetin, with an aim to evaluate its effects on bone health in comparison to free quercetin (Q).
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: